DA Davidson Downgrades Medifast to Neutral, Lowers Price Target to $74

DA Davidson downgrades Medifast (NYSE:MED) from Buy to Neutral and lowers the price target from $250 to $74.

Benzinga · 11/08/2019 13:38

DA Davidson downgrades Medifast (NYSE:MED) from Buy to Neutral and lowers the price target from $250 to $74.